Pfizer CentreOne — Revenues:
Pfizer Pfizer CentreOne — Revenues: increased by 5.9% to $289.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $273.00M to $289.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful expansion of the CDMO service business and higher utilization of manufacturing assets, while a decrease may indicate reduced demand for outsourced manufacturing or increased competition in the CDMO market.
Detailed definition
This metric represents the total revenue generated by the Pfizer CentreOne operating segment, which provides contract de...
Peer comparison
Comparable to CDMO revenue streams reported by other large pharmaceutical companies with internal manufacturing service divisions or independent CDMO firms like Lonza or Catalent.
pfe_segment_pfizer_centreone_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $437.00M | $521.00M | $382.00M | $273.00M | $289.00M |
| QoQ Change | — | +19.2% | -26.7% | -28.5% | +5.9% |
| YoY Change | — | — | — | — | +5.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's pfizer centreone — revenues:?
- Pfizer (PFE) reported pfizer centreone — revenues: of $289.00M in Q1 2026.
- How has Pfizer's pfizer centreone — revenues: changed year-over-year?
- Pfizer's pfizer centreone — revenues: increased by 5.9% year-over-year, from $273.00M to $289.00M.
- What does pfizer centreone — revenues: mean?
- Total revenue earned from providing contract manufacturing and development services to other pharmaceutical companies.